CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer using its Helicon™ ...

Oncology innovations, obesity medicines, an uptick for mergers and acquisitions, regulation for artificial intelligence applications and growing consumerization are expected to be key topics. 2025 ...

They are barely thicker than a human hair—yet they could significantly improve the effectiveness of inhaled medications: carrier particles in dry powder inhalers transport the active ingredient and ...

This former pharmaceutical exec figured out a brand-new way to finance treatments for global diseases. And he’s already doing it For finding an innovative way to finance the approval process for ...

In high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. But the transformation is just getting underway. By Steve Lohr Photographs by Spencer Lowell ...

Patient Perspectives on and Willingness to Pay for Navigation Services Billed Under Centers for Medicare & Medicaid Services Principal Illness Navigation Codes To counter the rising costs of new ...

Mr. Epstein brings more than 30 years of global drug development and commercialization experience to support Frontier’s next phase of growth as it continues to advance its pipeline of covalent ...

A major group of international experts and patients have cooperated in defining new parameters for the development of medicines to treat children and young people. They make a series of ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Praxis Precision Medicines, a clinical-stage, genetic neuroscience company, launched today with more than $100 million in financing since its inception from premier ...